Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (none)
1. Bismuth(3+) Tris(2-propylvalerate)
2. 94071-09-7
3. Unii-87ptx621fi
4. Bismuth Dipropylacetate
5. 87ptx621fi
6. Einecs 301-809-4
7. Einecs 262-199-2
8. Dtxsid50240373
9. 60364-28-5
10. Bismuth Dipropylacetate [who-dd]
11. Dtxsid60209133
12. Dtxcid50162864
13. Dtxcid80131624
14. Bismuth(3+) Tris(2-propylpentanoate)
15. Bismuth 2-propylvalerate
16. Schembl1311804
17. Yzdvvhsliplzlo-uhfffaoysa-k
18. Bismuth(3+)tris(2-propylvalerate)
19. Db13910
20. Ns00091875
21. Q27269835
| Molecular Weight | 638.6 g/mol |
|---|---|
| Molecular Formula | C24H45BiO6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 12 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 120 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 87.9 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
ABOUT THIS PAGE
76
PharmaCompass offers a list of Bismuth Valproate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bismuth Valproate manufacturer or Bismuth Valproate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bismuth Valproate manufacturer or Bismuth Valproate supplier.
A Bismuth Valproate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bismuth Valproate, including repackagers and relabelers. The FDA regulates Bismuth Valproate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bismuth Valproate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bismuth Valproate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Bismuth Valproate supplier is an individual or a company that provides Bismuth Valproate active pharmaceutical ingredient (API) or Bismuth Valproate finished formulations upon request. The Bismuth Valproate suppliers may include Bismuth Valproate API manufacturers, exporters, distributors and traders.
click here to find a list of Bismuth Valproate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Bismuth Valproate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bismuth Valproate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bismuth Valproate GMP manufacturer or Bismuth Valproate GMP API supplier for your needs.
A Bismuth Valproate CoA (Certificate of Analysis) is a formal document that attests to Bismuth Valproate's compliance with Bismuth Valproate specifications and serves as a tool for batch-level quality control.
Bismuth Valproate CoA mostly includes findings from lab analyses of a specific batch. For each Bismuth Valproate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bismuth Valproate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bismuth Valproate EP), Bismuth Valproate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bismuth Valproate USP).
